Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:04:03.720Z.
Calculation as of: 2026-10-06T16:04:03.720Z.
Quote observation: 2026-10-06T15:57:54.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 85842aa9b6cc8ebfa961f669867d571d507c26eab2d350d24b64fb3509ac0979
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Modular Medical, Inc.
Market Cap
$21.60M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$20.92M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$22.65M
Operating Cash Flow Yield
14.49%
TTM Avg
7.71%
3Y Avg
27.75%
5Y Avg
27.75%
Market Cap
$22.87M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.41M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.86M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$19.66M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$23.96M
Operating Cash Flow Yield
N/A
TTM Avg
2.45%
3Y Avg
2.44%
5Y Avg
2.12%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Modular Medical, Inc. (MODD) | $21.60M | N/A | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.92M | N/A | N/A | N/A | N/A |
| LeonaBio, Inc. (LONA)vs › | $22.28M | N/A | N/A | N/A | N/A |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.65M | 14.49% | 7.71% | 27.75% | 27.75% |
| Rein Therapeutics Inc. (RNTX)vs › | $22.87M | N/A | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.41M | N/A | N/A | N/A | N/A |
| Actuate Therapeutics Inc (ACTU)vs › | $19.86M | N/A | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $19.66M | N/A | N/A | N/A | N/A |
| Kyntra Bio, Inc. (KYNB)vs › | $23.96M | N/A | 2.45% | 2.44% | 2.12% |
| NextCure, Inc. (NXTC)vs › | $19.14M | N/A | 0.55% | 0.55% | 0.55% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
